Clearance in Primary Ciliary Dyskinesia (CLIP)
Evaluating Non-ciliary Mechanisms of Airway Clearance in Muco-obstructive Lung Disease
Understanding mechanisms of mucus clearance from the airways may lead to treatments in muco-obstructive lung conditions. Mucociliary clearance (MCC) scans are a way to measure the rate at which a person's lungs can clear inhaled particles. Through a single-arm pilot study in participants with primary ciliary dyskinesia (PCD), the investigators will evaluate the effect of exercise as a way to increase clearance through a mechanism called gas liquid transport (GLT) where the faster flow of air through the lungs during exercise is able to clear more particles. The investigators will repeat MCC measures with exercise after administering hypertonic saline (HS) to evaluate the effects of mucus hydration on both GLT and cough clearance (CC).
Aim 1. To quantify non-ciliary, non-cough mechanisms of mucus clearance (i.e., GLT) in PCD through an MCC protocol that introduces a standardized exercise intervention after isotope delivery.
Aim 2. To evaluate whether exercise-induced GLT and/or CC are responsive to hydrator intervention, using a short acting bronchodilator with 7% HS prior to isotope delivery followed by MCC with exercise intervention.
연구 개요
상세 설명
The investigators will perform an open label, single-arm interventional pilot study with all participants undergoing the interventions (exercise, and exercise with HS pretreatment) and serving as their own control to evaluate the effects of exercise on non-ciliary mucus clearance mechanisms in PCD to better identify role of GLT and CC. The investigators will also evaluate the effect of pretreatment with HS on GLT (if present) and CC, to determine if these mechanisms of mucus clearance are modifiable by future therapies in PCD and other muco-obstructive lung diseases.
Patients will be asked to attend a total of 3 study visits: screening visit 1 (V1), baseline exercise MCC (visit 2 (V2) or visit 3 (V3)), and HS pretreatment MCC (V2 or V3). Patients will be randomized to perform their baseline exercise MCC scan first or their HS pretreatment MCC scan first to minimize introduction of bias. The time between V1 and V2 will be 3 days to 28 days to allow for flexibility of scheduling, but participants already prescribed HS will be required to undergo a washout period of at least 3 days. V3 will take place at least 3 days after V2 to allow for remaining MCC isotope washout. At V1, tolerability and change in airway caliber in response to HS will be assessed by symptom assessment and spirometry, along with the performance of an exercise assessment to inform the exercise protocol in V2 and V3. From the baseline exercise MCC visit, the primary outcome of Whole Lung Total GLT will be measured. Through comparing the data from the exercise MCC visit and the HS pretreatment MCC visit, change in Whole Lung Total GLT and CC will be determined.
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Katherine A Despotes, MD
- 전화번호: 919-966-1055
- 이메일: katherine.despotes@unchealth.unc.edu
연구 연락처 백업
- 이름: Corinne Taylor
- 이메일: corinne.lawler@unc.edu
연구 장소
-
-
North Carolina
-
Chapel Hill, North Carolina, 미국, 27278
- University of North Carolina at Chapel Hill
-
연락하다:
- Katherine A Despotes, MD
- 전화번호: 919-966-1055
- 이메일: katherine.despotes@unchealth.unc.edu
-
연락하다:
- Corinne Taylor
- 이메일: corinne.lawler@unc.edu
-
수석 연구원:
- Katherine A Despotes, MD
-
-
참여기준
자격 기준
공부할 수 있는 나이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
설명
Inclusion Criteria:
- 18 years old or older
- Diagnosis of PCD with supporting genetics
- Lung function with forced expiratory volume in 1 second (FEV1) percent predicted >30%
- Ability to exercise for 20 minutes (Exercise Assessment performed at screening visit)
Exclusion Criteria:
- Intolerance to 7% HS
- Failure of HS tolerance test (HSTT) at visit 1 (V1), defined as a decline of 10% in FEV1 from baseline pre-bronchodilator (BD) FEV1 after 7% HS
- Intolerance to levalbuterol
- Exercise-induced asthma
- Complex congenital heart disease or other exercise limitation
- Lung transplantation or listed for lung transplantation
- History of lung resection of the lung analyzed by MCC (depending on situs status)
- Pregnancy or unwillingness to use approved birth control during study period
- Recent hemoptysis (>60 ml in the last 3 months)
- Pulmonary exacerbation in preceding 4 weeks
- Change in pulmonary therapies within preceding 4 weeks
- Resting or exertional O2 requirement (nocturnal acceptable)
- Tobacco / smoking history (any within last year, and >10 pack year history in past)
- More than 2 chest computed tomography (CT) scans in the past year or a combination of procedures believed to have exposed the lungs to >150 millisieverts (mSv), including from other research studies
- Participation in another interventional trial within 30 days
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 해당 없음
- 중재 모델: 단일 그룹 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Exercise with and without HS pretreatment
All participants will undergo interventions of exercise alone, and exercise with HS pretreatment, in two separate study visits according to randomization to intervention sequence.
|
At either V2 or V3, after 16 minutes of baseline MCC data collection, participants will perform 20 minutes of moderate-intensity exercise based on the Borg Rating of Perceived Exertion (RPE) scale, on a cycle ergometer.
The goal through this moderate intensity exercise is to increase respiratory rate and airflow velocity, thereby potentially inducing GLT.
Participants will then resume MCC scan data collection post-exercise to continue to measure the effects induced by exercise on clearance from the lungs.
At either V2 or V3, prior to the start of baseline MCC scanning, participants will undergo pretreatment with 4 puffs of inhaled levalbuterol (90 mcg per actuation, via spacer) followed by 4 ml of 7% HS via nebulizer.
Participants will then start MCC scan data collection, and after 16 minutes of baseline MCC collection they will then complete 20 minutes of moderate intensity exercise according to the Borg RPE on a cycle ergometer.
After 20 minutes, MCC scan will resume to continue to measure rates of clearance following HS pretreatment and exercise.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Whole Lung Total GLT
기간: Either Day 1 (Visit 2) or up to Day 28 (Visit 3) depending on randomization to sequence intervention
|
Through MCC scan with built in exercise protocol, the investigators will measure the effects of exercise on rates of clearance of radiolabeled isotopes from the lungs, thought to represent GLT.
The investigators will measure the difference between retained particles from immediately before (after collection of 16 minutes of baseline MCC data through eight 2-minute images) and immediately after 20 minutes of moderate intensity exercise on a cycle ergometer (40 minutes after start of MCC data collection).
This will represent Active GLT.
The investigators will then resume measurement of MCC clearance rate by serial 2-minute image collection of the whole lung from 40 minutes to 70 minutes.
This will represent Sustained GLT.
The sum of Active and Sustained GLT will represent Whole Lung GLT.
This measurement will occur at either Visit 2 or Visit 3, depending on visit sequence randomization.
|
Either Day 1 (Visit 2) or up to Day 28 (Visit 3) depending on randomization to sequence intervention
|
|
Change in Whole Lung Total GLT after HS pretreatment
기간: Day 3 to 28, depending on timing of Visit 3
|
After pretreatment with levalbuterol and 7% HS, participants will undergo an MCC scan with built in exercise protocol.
The investigators will measure the effects of exercise on rates of clearance of radiolabeled isotopes from the lungs, thought to represent GLT.
The investigators will measure Active GLT and Sustained GLT after HS pretreatment, which taken together will represent Whole Lung GLT after HS pretreatment.
This measurement will occur at either Visit 2 or Visit 3 depending on visit sequence randomization.
The difference between Whole Lung GLT from exercise alone will be compared with the HS pretreatment Whole Lung GLT.
|
Day 3 to 28, depending on timing of Visit 3
|
|
Change in Cough Clearance (CC) after HS Pretreatment
기간: Day 3 to 28, depending on timing of Visit 3
|
The investigators will measure the effects of exercise and HS pretreatment on rates of clearance of radiolabeled isotopes from the lungs during a period of controlled coughs at regular intervals.
During Visit 2 and Visit 3 MCC scans, from minutes 70 through 100 of MCC data collection, participants will be instructed to perform 30 voluntary huff-cough maneuvers while serial 2-minute images are obtained.
The change in clearance during this time will represent CC.
At one of these visits (either Visit 2 or Visit 3 depending on randomization to intervention sequence), participants will undergo pretreatment with levalbuterol and 7% HS prior to the MCC scan with exercise protocol.
The difference between CC after exercise alone and CC after exercise with HS pretreatment will be measured.
|
Day 3 to 28, depending on timing of Visit 3
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Katherine A Despotes, MD, University of North Carolina, Chapel Hill
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- 25-1650
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
미국에서 제조되어 미국에서 수출되는 제품
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
원발성 섬모 운동 이상증에 대한 임상 시험
-
Cairo University아직 모집하지 않음
-
Capital Medical University완전한Transradial Approach, Primary PCI, ST-segment Elevation 심근경색증중국
Exercise에 대한 임상 시험
-
Cukurova University완전한
-
University of TorontoUniversity Health Network, Toronto; University of Western Ontario, Canada; Institute for... 그리고 다른 협력자들완전한
-
The Hong Kong Polytechnic University완전한
-
University of Maryland, BaltimoreNational Institute on Aging (NIA)완전한